These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11900945)
21. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Mendes RE; Deshpande LM; Jones RN Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801 [TBL] [Abstract][Full Text] [Related]
22. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens]. Manfredi R Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159 [TBL] [Abstract][Full Text] [Related]
23. The oxazolidinones as a new family of antimicrobial agent. Marchese A; Schito GC Clin Microbiol Infect; 2001; 7 Suppl 4():66-74. PubMed ID: 11688536 [TBL] [Abstract][Full Text] [Related]
24. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Maclayton DO; Hall RG Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012 [TBL] [Abstract][Full Text] [Related]
25. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733 [TBL] [Abstract][Full Text] [Related]
26. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Puzniak LA; Morrow LE; Huang DB; Barreto JN Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955 [TBL] [Abstract][Full Text] [Related]
27. Gut overgrowth of vancomycin-resistant enterococci (VRE) results in linezolid-resistant mutation in a child with severe congenital neutropenia: a case report. Verma N; Clarke RW; Bolton-Maggs PH; van Saene HK J Pediatr Hematol Oncol; 2007 Aug; 29(8):557-60. PubMed ID: 17762497 [TBL] [Abstract][Full Text] [Related]
28. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections. Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021 [TBL] [Abstract][Full Text] [Related]
30. [Role of linezolid in antimicrobial therapy]. Carmona PM; Romá E; Monte E; García J; Gobernado M Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042 [TBL] [Abstract][Full Text] [Related]
31. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid. Maranich AM; Rajnik M Mil Med; 2008 Sep; 173(9):927-9. PubMed ID: 18816936 [TBL] [Abstract][Full Text] [Related]
32. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid]. Krueger WA; Unertl KE Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745 [TBL] [Abstract][Full Text] [Related]
33. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment]. Pangercić A; Bukovski-Simonoski S; Barsić B Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711 [TBL] [Abstract][Full Text] [Related]
34. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci. Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924 [TBL] [Abstract][Full Text] [Related]
35. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis. Sipahi OR; Bardak-Ozcem S; Turhan T; Arda B; Ruksen M; Pullukcu H; Aydemir S; Dalbasti T; Yurtseven T; Sipahi H; Zileli M; Ulusoy S Surg Infect (Larchmt); 2013 Aug; 14(4):357-62. PubMed ID: 23672240 [TBL] [Abstract][Full Text] [Related]
36. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739 [TBL] [Abstract][Full Text] [Related]
37. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. Chuang YC; Wang JT; Lin HY; Chang SC BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance among gram-positive organisms in the intensive care unit. Clark NM; Hershberger E; Zervosc MJ; Lynch JP Curr Opin Crit Care; 2003 Oct; 9(5):403-12. PubMed ID: 14508154 [TBL] [Abstract][Full Text] [Related]
39. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Zeana C; Kubin CJ; Della-Latta P; Hammer SM Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183 [TBL] [Abstract][Full Text] [Related]
40. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci]. Aktaş G; Bozdoğan B; Derbentli S Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]